Product Information

LACOSAMIDE 150 MG TABLET is a generic product labeled by Tris Pharma Inc, priced at $0.2856 per EA under NDC 27808024501. Its NADAC has been published 142 times since Jun 22, 2022.

The High Outlier badge above means this manufacturer's average price in the Lacosamide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

LACOSAMIDE 150 MG TABLET

Lacosamide
$0.2856per EA
High Outlier
DEA Schedule CV

Strength

150 mg/1

Manufacturer

Tris Pharma Inc

NDC

27808024501

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

2/19/2025

Active Ingredients

LACOSAMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA208308

On Market Since

3/19/2022

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for LACOSAMIDE 150 MG TABLET has been published 142 times since Jun 22, 2022, and over the history we have for it it has declined 33.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2856 per EA
All-time high$0.4317 (Jul 13, 2022)
All-time low$0.2227 (Nov 20, 2024)
Median price$0.3650
Average price$0.3551
Largest weekly change+42.0% (Aug 21, 2024)
Weeks tracked142
Tracking sinceJun 22, 2022

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

-25.3%

5Y

N/A

All

-33.8%

Generic Alternatives

The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 28% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LACOSAMIDE 150 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LACOSAMIDE 150 MG TABLET, manufactured by Tris Pharma Inc, is $0.2856 per EA (NDC 27808024501), effective Mar 5, 2025.

How has the price of LACOSAMIDE 150 MG TABLET changed over time?

Over the history we have for it, the NADAC for LACOSAMIDE 150 MG TABLET has declined 33.8%. It has been tracked across 142 weekly CMS publications since Jun 22, 2022.

What are the highest and lowest recorded NADAC prices for LACOSAMIDE 150 MG TABLET?

Since Jun 22, 2022, the NADAC for LACOSAMIDE 150 MG TABLET has ranged from a low of $0.2227 (Nov 20, 2024) to a high of $0.4317 (Jul 13, 2022), with a median of $0.3650 per EA.

Are there cheaper alternatives to LACOSAMIDE 150 MG TABLET?

Yes. 8 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LACOSAMIDE 150 MG TABLET, is $0.2069 per EA — about 28% below LACOSAMIDE 150 MG TABLET.

Who manufactures LACOSAMIDE 150 MG TABLET?

LACOSAMIDE 150 MG TABLET (NDC 27808024501) is labeled by Tris Pharma Inc, and CMS classifies it as a generic product.